BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 22212250)

  • 1. TMED2/p24β1 is expressed in all gestational stages of human placentas and in choriocarcinoma cell lines.
    Zakariyah A; Hou W; Slim R; Jerome-Majewska L
    Placenta; 2012 Mar; 33(3):214-9. PubMed ID: 22212250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunomodulatory proteins B7-DC, B7-H2, and B7-H3 are differentially expressed across gestation in the human placenta.
    Petroff MG; Kharatyan E; Torry DS; Holets L
    Am J Pathol; 2005 Aug; 167(2):465-73. PubMed ID: 16049332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMED2 promotes glioma tumorigenesis by being involved in EGFR recycling transport.
    Sun C; Zhang Y; Wang Z; Chen J; Zhang J; Gu Y
    Int J Biol Macromol; 2024 Mar; 262(Pt 2):130055. PubMed ID: 38354922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into cAMP-dependent molecular mechanisms regulating expression and function of LGALS16 gene in choriocarcinoma JEG-3 cells.
    Kaminker JD; Butt AG; Killeen H; Timoshenko AV
    Cell Biol Int; 2024 Mar; 48(3):378-385. PubMed ID: 38212900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of gene expression changes over healthy term pregnancies.
    Knight AK; Dunlop AL; Kilaru V; Cobb D; Corwin EJ; Conneely KN; Smith AK
    PLoS One; 2018; 13(10):e0204228. PubMed ID: 30303981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The circular RNA CDR1as regulate cell proliferation via TMED2 and TMED10.
    Yang X; Li S; Wu Y; Ge F; Chen Y; Xiong Q
    BMC Cancer; 2020 Apr; 20(1):312. PubMed ID: 32293333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMED2 promotes epithelial ovarian cancer growth.
    Shi-Peng G; Chun-Lin C; Huan W; Fan-Liang M; Yong-Ning C; Ya-Di Z; Guang-Ping Z; Ye-Ping C
    Oncotarget; 2017 Nov; 8(55):94151-94165. PubMed ID: 29212217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and Importance of TMED2 in Multiple Myeloma Cells.
    Ge X; Jiang W; Jiang Y; Lv X; Liu X; Wang X
    Cancer Manag Res; 2020; 12():12895-12903. PubMed ID: 33364837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMED family genes and their roles in human diseases.
    Zhou L; Li H; Yao H; Dai X; Gao P; Cheng H
    Int J Med Sci; 2023; 20(13):1732-1743. PubMed ID: 37928880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Snrpb is required in murine neural crest cells for proper splicing and craniofacial morphogenesis.
    Alam SS; Kumar S; Beauchamp MC; Bareke E; Boucher A; Nzirorera N; Dong Y; Padilla R; Zhang SJ; Majewski J; Jerome-Majewska LA
    Dis Model Mech; 2022 Jun; 15(6):. PubMed ID: 35593225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trafficking protein TMED3 promotes esophageal squamous cell carcinoma.
    Yang Y; Liu S; Xie C; Li Q; Gao T; Liu M; Xi M; Zhao L
    Biomed J; 2023 Apr; 46(2):100528. PubMed ID: 35358714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of TMED3 is independently associated with colorectal cancer prognosis.
    Wang RF; Hong YG; Hao LQ; Yu HT
    Exp Ther Med; 2022 Apr; 23(4):286. PubMed ID: 35317448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmembrane p24 trafficking protein 2 regulates inflammation through the TLR4/NF-κB signaling pathway in lung adenocarcinoma.
    Feng L; Cheng P; Feng Z; Zhang X
    World J Surg Oncol; 2022 Feb; 20(1):32. PubMed ID: 35135563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation in Eftud2 causes craniofacial defects in mice via mis-splicing of Mdm2 and increased P53.
    Beauchamp MC; Djedid A; Bareke E; Merkuri F; Aber R; Tam AS; Lines MA; Boycott KM; Stirling PC; Fish JL; Majewski J; Jerome-Majewska LA
    Hum Mol Genet; 2021 May; 30(9):739-757. PubMed ID: 33601405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmembrane emp24 domain proteins in development and disease.
    Aber R; Chan W; Mugisha S; Jerome-Majewska LA
    Genet Res (Camb); 2019 Dec; 101():e14. PubMed ID: 31878985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of TMED2 is an unfavorable prognostic factor in patients with breast cancer.
    Lin X; Liu J; Hu SF; Hu X
    Cancer Manag Res; 2019; 11():2203-2214. PubMed ID: 31114314
    [No Abstract]   [Full Text] [Related]  

  • 17. TMED3 promotes cell proliferation and motility in breast cancer and is negatively modulated by miR-188-3p.
    Pei J; Zhang J; Yang X; Wu Z; Sun C; Wang Z; Wang B
    Cancer Cell Int; 2019; 19():75. PubMed ID: 30976199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2.
    Hou W; Gupta S; Beauchamp MC; Yuan L; Jerome-Majewska LA
    PLoS One; 2017; 12(8):e0182995. PubMed ID: 28797121
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.